State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Cell Prolif. 2012 Dec;45(6):487-98. doi: 10.1111/j.1365-2184.2012.00845.x. Epub 2012 Oct 3.
Programmed cell death (PCD), referring to apoptosis, autophagy and programmed necrosis, is proposed to be death of a cell in any pathological format, when mediated by an intracellular program. These three forms of PCD may jointly decide the fate of cells of malignant neoplasms; apoptosis and programmed necrosis invariably contribute to cell death, whereas autophagy can play either pro-survival or pro-death roles. Recent bulk of accumulating evidence has contributed to a wealth of knowledge facilitating better understanding of cancer initiation and progression with the three distinctive types of cell death. To be able to decipher PCD signalling pathways may aid development of new targeted anti-cancer therapeutic strategies. Thus in this review, we present a brief outline of apoptosis, autophagy and programmed necrosis pathways and apoptosis-related microRNA regulation, in cancer. Taken together, understanding PCD and the complex interplay between apoptosis, autophagy and programmed necrosis may ultimately allow scientists and clinicians to harness the three types of PCD for discovery of further novel drug targets, in the future cancer treatment.
程序性细胞死亡(PCD),指细胞凋亡、自噬和程序性细胞坏死,是指当由细胞内程序介导时,任何病理形式的细胞死亡。这三种形式的 PCD 可能共同决定恶性肿瘤细胞的命运;凋亡和程序性细胞坏死总是导致细胞死亡,而自噬可以发挥生存或死亡的作用。最近大量积累的证据为更好地理解癌症的发生和发展提供了丰富的知识,这三种独特类型的细胞死亡。能够破译 PCD 信号通路可能有助于开发新的靶向抗癌治疗策略。因此,在这篇综述中,我们简要概述了凋亡、自噬和程序性细胞坏死途径以及与凋亡相关的 microRNA 调控在癌症中的作用。总之,理解 PCD 以及凋亡、自噬和程序性细胞坏死之间的复杂相互作用,可能最终使科学家和临床医生能够利用这三种 PCD 来发现未来癌症治疗的进一步新的药物靶点。